These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 12728572)

  • 21. Laboratory markers of alcoholism.
    Leggett BA; Powell LW; Halliday JW
    Dig Dis; 1989; 7(3):125-34. PubMed ID: 2567217
    [No Abstract]   [Full Text] [Related]  

  • 22. [CDT: a biological marker of alcohol abuse].
    Crespi V; Andreotta U; Tettamanzi E; Ferrario MM
    Med Lav; 2007; 98(6):466-74. PubMed ID: 18041466
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The diagnostic validity of screening tests and laboratory markers in alcohol use disorders].
    Gül S; Akvardar Y; Taş G; Tuncel P
    Turk Psikiyatri Derg; 2005; 16(1):3-12. PubMed ID: 15793693
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biochemical alcohol screening in primary health care.
    Miller PM; Anton RF
    Addict Behav; 2004 Sep; 29(7):1427-37. PubMed ID: 15345274
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Carbohydrate deficient transferrin: a new biochemical marker for chronic, excessive alcohol abuse].
    van den Bergh FA; Vermes I
    Ned Tijdschr Geneeskd; 1997 Jun; 141(24):1212. PubMed ID: 9380160
    [No Abstract]   [Full Text] [Related]  

  • 26. Screening trauma patients with the alcohol use disorders identification test and biomarkers of alcohol use.
    Neumann T; Gentilello LM; Neuner B; Weiss-Gerlach E; Schürmann H; Schröder T; Müller C; Haas NP; Spies CD
    Alcohol Clin Exp Res; 2009 Jun; 33(6):970-6. PubMed ID: 19302090
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of the combined marker GGT-CDT and the conventional laboratory markers of alcohol abuse in heavy drinkers, moderate drinkers and abstainers.
    Hietala J; Koivisto H; Anttila P; Niemelä O
    Alcohol Alcohol; 2006; 41(5):528-33. PubMed ID: 16799164
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DOVER and QUVER-new marker combinations to detect and monitor at-risk drinking.
    Berner MM; Bentele M; Kriston L; Mänz C; Clement HW; Härter M; Mundle G
    Alcohol Clin Exp Res; 2006 Aug; 30(8):1372-80. PubMed ID: 16899040
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detecting alcohol abuse: the value of carbohydrate deficient transferrin.
    Stout RL
    J Insur Med; 1998; 30(2):123-4. PubMed ID: 10339297
    [No Abstract]   [Full Text] [Related]  

  • 30. [Biomarkers of alcohol abuse. Part I. Traditional biomarkers and their interpretation].
    Waszkiewicz N; Konarzewska B; Waszkiewicz M; Popławska R; Szajda SD; Zalewska A; Markowski T; Szulc A
    Psychiatr Pol; 2010; 44(1):127-36. PubMed ID: 20449986
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Carbohydrate-deficient transferrin (CDT) as a marker of alcohol abuse: a critical review of the literature 2001-2005.
    Bortolotti F; De Paoli G; Tagliaro F
    J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Sep; 841(1-2):96-109. PubMed ID: 16725384
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of biomarkers for alcoholism by two-dimensional differential gel electrophoresis.
    Wu D; Tomonaga T; Sogawa K; Satoh M; Sunaga M; Nezu M; Oh-Ishi M; Kodera Y; Maeda T; Ochiai T; Nomura F
    Alcohol Clin Exp Res; 2007 Jan; 31(1 Suppl):S67-71. PubMed ID: 17331169
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alcohol consumption, %CDT, GGT and blood pressure change during alcohol treatment.
    Baros AM; Wright TM; Latham PK; Miller PM; Anton RF
    Alcohol Alcohol; 2008; 43(2):192-7. PubMed ID: 18039674
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Innovative technologies for the diagnosis of alcohol abuse and monitoring abstinence.
    Bean P; Harasymiw J; Peterson CM; Javors M
    Alcohol Clin Exp Res; 2001 Feb; 25(2):309-16. PubMed ID: 11236848
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A useful test for monitoring alcohol use.
    Miller PM; Cluver J; Anton RF
    Behav Healthc; 2009 Jun; 29(6):38, 40. PubMed ID: 19655583
    [No Abstract]   [Full Text] [Related]  

  • 36. [Usefulness of biological markers in the detection of alcoholism in primary care situations].
    Med Clin (Barc); 1989 Apr; 92(13):518-9. PubMed ID: 2568517
    [No Abstract]   [Full Text] [Related]  

  • 37. Phosphatidylethanol as a sensitive and specific biomarker: comparison with gamma-glutamyl transpeptidase, mean corpuscular volume and carbohydrate-deficient transferrin.
    Hartmann S; Aradottir S; Graf M; Wiesbeck G; Lesch O; Ramskogler K; Wolfersdorf M; Alling C; Wurst FM
    Addict Biol; 2007 Mar; 12(1):81-4. PubMed ID: 17407500
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Bayesian Alcoholism Test had better diagnostic properties for confirming diagnosis of hazardous and harmful alcohol use.
    Korzec A; de Bruijn C; van Lambalgen M
    J Clin Epidemiol; 2005 Oct; 58(10):1024-32. PubMed ID: 16168348
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of laboratory markers and the audit questionnaire by primary care physicians to detect alcohol abuse by patients.
    Aalto M; Seppä K
    Alcohol Alcohol; 2005; 40(6):520-3. PubMed ID: 16215269
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical evaluation of various screening tests for alcoholism].
    Artese D; Antidormi G; Cau N; Di Nicola A; Di Tomasso E; Renzi D; Santilli DL; Santilli S; Albani A
    Minerva Med; 1982 May; 73(21):1441-8. PubMed ID: 6123966
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.